Our results demonstrate that RARRES1 may protect RPE cells from oxidative stress-induced damage via the JNK/SIRT1/Nrf2 signaling axis, providing insight into its potential as a therapeutic target for AMD. This evidence concerns the gene MAPK8 and age-related macular degeneration.